Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis.
作者信息
Daza Jorge, Gul Zeynep, Sfakianos John P
机构信息
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Transl Androl Urol. 2019 Jul;8(Suppl 3):S240-S241. doi: 10.21037/tau.2019.01.11.
Abstract
摘要
相似文献
1
Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis.热休克蛋白在膀胱癌中的作用：治疗反应和肿瘤预后的潜在生物标志物
Transl Androl Urol. 2019 Jul;8(Suppl 3):S240-S241. doi: 10.21037/tau.2019.01.11.
2
A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer.热休克蛋白和烟酰胺N-甲基转移酶在预测膀胱癌放疗反应中的潜在作用。
Int J Cancer. 2002 Oct 10;101(5):454-60. doi: 10.1002/ijc.10631.
3
Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer.癌症中热休克蛋白的临床、预后和治疗意义。
Curr Drug Targets. 2018;19(13):1478-1490. doi: 10.2174/1389450118666170823121248.
4
Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy.热休克蛋白60和70与经膀胱灌注卡介苗免疫治疗的T1期高级别膀胱尿路上皮肿瘤的长期预后相关。
Urol Oncol. 2018 Dec;36(12):531.e9-531.e17. doi: 10.1016/j.urolonc.2018.09.007. Epub 2018 Oct 15.
5
Clinical significance of heat shock protein-70 expression in bladder cancer.热休克蛋白-70在膀胱癌中的表达的临床意义
Urology. 2003 Mar;61(3):677-80. doi: 10.1016/s0090-4295(02)02289-6.
6
Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer.膀胱尿路上皮癌新辅助化疗后膀胱切除术前上皮肿瘤标志物反应与肿瘤学结局之间的关联
Urol Oncol. 2019 Jan;37(1):1-11. doi: 10.1016/j.urolonc.2018.09.008. Epub 2018 Nov 20.
7
Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat.
Br J Cancer. 1995 Sep;72(3):620-6. doi: 10.1038/bjc.1995.383.
8
Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.热休克蛋白：癌症发展的作用因子和癌症治疗中的治疗靶点。
Cells. 2019 Dec 24;9(1):60. doi: 10.3390/cells9010060.
9
Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.抗热休克蛋白自身抗体作为癌症诊断和预后的生物标志物。
Cancer Biomark. 2017;18(2):105-116. doi: 10.3233/CBM-160117.
10
Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.联合抑制热休克蛋白90和70会导致参与肌肉浸润性膀胱癌的致癌信号蛋白同时降解。
Oncotarget. 2015 Nov 24;6(37):39821-38. doi: 10.18632/oncotarget.5496.
引用本文的文献
1
Effect of silver nanoparticles on gene transcription of land snail Helix aspersa.银纳米粒子对陆生蜗牛 H. aspersa 基因转录的影响。
Sci Rep. 2022 Feb 8;12(1):2078. doi: 10.1038/s41598-022-06090-1.
本文引用的文献
1
Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy.热休克蛋白60和70与经膀胱灌注卡介苗免疫治疗的T1期高级别膀胱尿路上皮肿瘤的长期预后相关。
Urol Oncol. 2018 Dec;36(12):531.e9-531.e17. doi: 10.1016/j.urolonc.2018.09.007. Epub 2018 Oct 15.
2
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南：非肌层浸润性膀胱尿路上皮癌：2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
3
HSP70-based anti-cancer immunotherapy.基于热休克蛋白70的抗癌免疫疗法。
Hum Vaccin Immunother. 2016 Oct 2;12(10):2529-2535. doi: 10.1080/21645515.2016.1190057. Epub 2016 Jun 13.
4
Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer.用于癌症治疗的热休克蛋白-肽及基于热休克蛋白的免疫疗法
Front Immunol. 2016 Apr 29;7:171. doi: 10.3389/fimmu.2016.00171. eCollection 2016.
5
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.EORTC 列线图和风险分组用于预测非肌肉浸润性 Ta-T1 期尿路上皮膀胱癌患者接受 1-3 年卡介苗维持治疗后的复发、进展、疾病特异性和总生存情况。
Eur Urol. 2016 Jan;69(1):60-9. doi: 10.1016/j.eururo.2015.06.045. Epub 2015 Jul 23.
6
The role of heat shock proteins in bladder cancer.热休克蛋白在膀胱癌中的作用。
Nat Rev Urol. 2013 Jul;10(7):386-95. doi: 10.1038/nrurol.2013.108. Epub 2013 May 14.
7
Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.抗癌药物导致人肝癌细胞释放含有热休克蛋白的外泌体，在体外引发有效的自然杀伤细胞抗肿瘤反应。
J Biol Chem. 2012 May 4;287(19):15874-85. doi: 10.1074/jbc.M112.340588. Epub 2012 Mar 6.
8
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.热休克蛋白 70-2（HSP70-2）在膀胱尿路上皮癌中的表达与肿瘤进展相关，并促进迁移和侵袭。
Eur J Cancer. 2010 Jan;46(1):207-15. doi: 10.1016/j.ejca.2009.10.020.
9
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.使用欧洲癌症研究与治疗组织（EORTC）风险表预测Ta T1期膀胱癌个体患者的复发和进展：来自七项EORTC试验的2596例患者的综合分析
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. doi: 10.1016/j.eururo.2005.12.031. Epub 2006 Jan 17.
10
Clinical significance of heat shock protein-70 expression in bladder cancer.热休克蛋白-70在膀胱癌中的表达的临床意义
Urology. 2003 Mar;61(3):677-80. doi: 10.1016/s0090-4295(02)02289-6.
Zotero 插件